Menu ×

HEALTHCARE & PHARMACEUTICAL

Atenolol Market Segmentation by Form (Tablets, IV Solution, and Others); by Dosage Type (25mg, 50mg, and 100 mg); by Application (Hypertension, Angina, Arrhythmias, and Others); and by End-User (Hospital Pharmacies, Drug Store, Online Pharmacy, and Others) – Global Demand Analysis & Opportunity Outlook 2031

  • Text Size:

Extensive insights into the Growth of Atenolol Market amidst COVID-19

Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.

Request Insights


IN THE NEWS

  • September 23, 2021: ViiV Healthcare, collectively owned by GlaxoSmithKline plc, Pfizer Inc. and Shionogi announced approval of the U.S. Food and Drug Administration (FDA) for drug Cabotegravir.

  • October 3, 2018: Ipca Pharmaceuticals Inc., announced that it has acquired Bayshore Pharmaceuticals LLC, a sales and marketing company of FDA approved generic drug products in the United States of America.

Global Atenolol Market Highlights over 2022 – 2031

The global atenolol market is estimated to grow at a substantial CAGR over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the increasing incidences of cardiac disorders, including, hypertensin, angina, and others. According to the data by the World Health Organization (WHO), an estimated 1.28 billion adults aged 30-79 years worldwide have hypertension. Atenolol is a beta blocker medication, primarily used to treat high blood pressure and other heart associated diseases. The unhealthy lifestyle prevalent amongst the majority of the population, leads to accumulation of cholesterol in the arteries. This causes issues, such as, high blood pressure, tachycardia, or angina. The growing dominance of poor lifestyle, such as, unhealthy eating habits, lack of physical activities, and excessive drinking, is anticipated to drive the growth of the market. Moreover, the rising geriatric population on a global level, is further estimated to boost the market growth. According to the data by the World Bank, 723,484,054 individuals were aged above 64 years of age, as of 2020.  

Atenolol Market Graph

Get more information on this report: Request Sample PDF

The market is segmented by application into hypertension, angina, arrhythmias, and others, out of which, the hypertension segment is anticipated to hold a substantial share in the global atenolol market over the forecast period on account of increasing cases of high blood pressure across the world. As per a report by the WHO, it is estimated that 46% of adults with hypertension are unaware that they have the condition. Moreover, hypertension can cause serious damage to the heart, which is why, patients are paying utmost attention to the medications that keep hypertension under control. Such factors are estimated to boost the segment growth.

Major Macro-Economic Indicators Impacting the Market Growth

Global Healthcare Expenditure per Capita Graph

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.  

Global Atenolol Market Regional Synopsis

On the basis of geographical analysis, the global atenolol market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Europe region is estimated to witness noteworthy growth over the forecast period, as the region has witnessed a sharp hike in the cases of heart related diseases. Moreover, efficient and inexpensive healthcare facilities in the developed countries are estimated to support the growth of the market.  

The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the increasing availability of advanced treatment and medications, coupled with the growing prevalence of cardiac diseases in the region. Approximately one in every 18 people, or 5% of the U.S. population has arrhythmia. Furthermore, as per the statistics by the Center for Disease Control and Prevention, in the U.S., 116 million individuals have hypertension, and in 2019, 0.5 million deaths were caused directly or indirectly by hypertension.

Atenolol Market Share Graph

Get more information on this report: Request Sample PDF

The global atenolol market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global atenolol market includes the following segments:

By Form

  • Tablets
  • IV Solution
  • Others

By Dosage Type

  • 25 mg
  • 50 mg
  • 100 mg

By Application

  • Hypertension
  • Angina
  • Arrhythmias
  • Others

By End-User

  • Hospital Pharmacies
  • Drug Store
  • Online Pharmacy
  • Others

Growth Drivers

  • Increasing Cases of Angina and Hypertension 
  • Poor Lifestyle and Dietary Habits among the People
  • Growing Awareness regarding Cardiac Diseases

Challenges

  • Availability of Diuretics and other Drugs

Top Featured Companies Dominating the Market

  • Intas Pharmaceuticals Limited
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Sysmex Corporation
  • Becton, Dickinson and Company
  • Zydus Pharmaceuticals Inc.
  • Ipca Laboratories Limited
  • Siemens Healthineers AG

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved